122 related articles for article (PubMed ID: 10779632)
1. Loss of IGF-II imprinting in endometrial tumors: overexpression in carcinosarcoma.
Roy RN; Gerulath AH; Cecutti A; Bhavnani BR
Cancer Lett; 2000 May; 153(1-2):67-73. PubMed ID: 10779632
[TBL] [Abstract][Full Text] [Related]
2. Discordant expression of insulin-like growth factors and their receptor messenger ribonucleic acids in endometrial carcinomas relative to normal endometrium.
Roy RN; Gerulath AH; Cecutti A; Bhavnani BR
Mol Cell Endocrinol; 1999 Jul; 153(1-2):19-27. PubMed ID: 10459850
[TBL] [Abstract][Full Text] [Related]
3. Relaxation of insulin-like growth factor-II gene imprinting in human gynecologic tumors.
Yaginuma Y; Nishiwaki K; Kitamura S; Hayashi H; Sengoku K; Ishikawa M
Oncology; 1997; 54(6):502-7. PubMed ID: 9394848
[TBL] [Abstract][Full Text] [Related]
4. Effect of tamoxifen treatment on the endometrial expression of human insulin-like growth factors and their receptor mRNAs.
Roy RN; Gerulath AH; Cecutti A; Bhavnani BR
Mol Cell Endocrinol; 2000 Jul; 165(1-2):173-8. PubMed ID: 10940495
[TBL] [Abstract][Full Text] [Related]
5. Loss of imprinting of IGF-II gene in children with acute lymphoblastic leukemia.
Vorwerk P; Wex H; Bessert C; Hohmann B; Schmidt U; Mittler U
Leuk Res; 2003 Sep; 27(9):807-12. PubMed ID: 12804639
[TBL] [Abstract][Full Text] [Related]
6. Genomic imprinting of IGF-II and H19 in adult human pancreatic tissues.
Micha AE; Hähnel S; Friess H; Büchler MW; Adler G; Gress TM
Digestion; 1999; 60(5):477-83. PubMed ID: 10473973
[TBL] [Abstract][Full Text] [Related]
7. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
Vu TH; Hoffman A
J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549
[TBL] [Abstract][Full Text] [Related]
8. Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer.
Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY
Clin Cancer Res; 2000 Feb; 6(2):474-9. PubMed ID: 10690526
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the IGF system and analysis of the possible molecular mechanisms leading to IGF-II overexpression in a mesothelioma.
Hodzic D; Delacroix L; Willemsen P; Bensbaho K; Collette J; Broux R; Lefèbvre P; Legros JJ; Grooteclaes M; Winkler R
Horm Metab Res; 1997 Nov; 29(11):549-55. PubMed ID: 9479554
[TBL] [Abstract][Full Text] [Related]
10. Alterations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF-II.
Kim SJ; Park SE; Lee C; Lee SY; Jo JH; Kim JM; Oh YK
Biochim Biophys Acta; 2002 Apr; 1586(3):307-15. PubMed ID: 11997082
[TBL] [Abstract][Full Text] [Related]
11. [Insulin-like growth factor II and its receptor gene expression in the endometrium of women with unexplained infertility].
Wu RJ; Zhou FZ
Zhonghua Fu Chan Ke Za Zhi; 2004 Apr; 39(4):242-5. PubMed ID: 15130350
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor II in uterine smooth-muscle tumors: maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata.
Vu TH; Yballe C; Boonyanit S; Hoffman AR
J Clin Endocrinol Metab; 1995 May; 80(5):1670-6. PubMed ID: 7745016
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factors and insulin-like growth factor binding proteins in the endometrium. Effect of intrauterine levonorgestrel delivery.
Rutanen EM
Hum Reprod; 2000 Aug; 15 Suppl 3():173-81. PubMed ID: 11041233
[TBL] [Abstract][Full Text] [Related]
14. Regional loss of imprinting of the insulin-like growth factor II gene occurs in human prostate tissues.
Jarrard DF; Bussemakers MJ; Bova GS; Isaacs WB
Clin Cancer Res; 1995 Dec; 1(12):1471-8. PubMed ID: 9815946
[TBL] [Abstract][Full Text] [Related]
15. Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors.
Merritt MA; Strickler HD; Einstein MH; Yang HP; Sherman ME; Wentzensen N; Brouwer-Visser J; Cossio MJ; Whitney KD; Yu H; Gunter MJ; Huang GS
Cancer Causes Control; 2016 Jun; 27(6):737-48. PubMed ID: 27125830
[TBL] [Abstract][Full Text] [Related]
16. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
[TBL] [Abstract][Full Text] [Related]
17. IGF-II in primary human colorectal tumors: peptide level, activated promoters, parental imprinting and gene rearrangement.
Winkler R; Delacroix L; Bensbaho K; Lambert S; Collette J; Hodzic D
Horm Metab Res; 1999; 31(2-3):148-54. PubMed ID: 10226796
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle.
Zhou J; Dsupin BA; Giudice LC; Bondy CA
J Clin Endocrinol Metab; 1994 Dec; 79(6):1723-34. PubMed ID: 7527408
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of messenger ribonucleic acids encoding insulin-like growth factors and their receptors in human uterine endometrium and decidua.
Giudice LC; Dsupin BA; Jin IH; Vu TH; Hoffman AR
J Clin Endocrinol Metab; 1993 May; 76(5):1115-22. PubMed ID: 8496300
[TBL] [Abstract][Full Text] [Related]
20. mRNA expression of insulin-like growth factor-I (IGF-I) is suppressed and those of IGF-II and IGF-binding protein-1 are constantly expressed in the endometrium during use of an intrauterine levonorgestrel system.
Rutanen EM; Salmi A; Nyman T
Mol Hum Reprod; 1997 Sep; 3(9):749-54. PubMed ID: 9357999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
